These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29165225)

  • 41. Diagnosis, clinical presentation, and in-hospital mortality of severe malaria in HIV-coinfected children and adults in Mozambique.
    Hendriksen IC; Ferro J; Montoya P; Chhaganlal KD; Seni A; Gomes E; Silamut K; Lee SJ; Lucas M; Chotivanich K; Fanello CI; Day NP; White NJ; von Seidlein L; Dondorp AM
    Clin Infect Dis; 2012 Oct; 55(8):1144-53. PubMed ID: 22752514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures.
    Johnson M; Grinsztejn B; Rodriguez C; Coco J; DeJesus E; Lazzarin A; Lichtenstein K; Wirtz V; Rightmire A; Odeshoo L; McLaren C
    AIDS; 2006 Mar; 20(5):711-8. PubMed ID: 16514301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults.
    Dal-Bianco MP; Köster KB; Kombila UD; Kun JF; Grobusch MP; Ngoma GM; Matsiegui PB; Supan C; Salazar CL; Missinou MA; Issifou S; Lell B; Kremsner P
    Am J Trop Med Hyg; 2007 Nov; 77(5):939-42. PubMed ID: 17984357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular evaluation of the natural history of asymptomatic parasitemia in Ugandan children.
    Nsobya SL; Parikh S; Kironde F; Lubega G; Kamya MR; Rosenthal PJ; Dorsey G
    J Infect Dis; 2004 Jun; 189(12):2220-6. PubMed ID: 15181569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children.
    Sáez-Llorens X; Violari A; Deetz CO; Rode RA; Gomez P; Handelsman E; Pelton S; Ramilo O; Cahn P; Chadwick E; Allen U; Arpadi S; Castrejón MM; Heuser RS; Kempf DJ; Bertz RJ; Hsu AF; Bernstein B; Renz CL; Sun E
    Pediatr Infect Dis J; 2003 Mar; 22(3):216-24. PubMed ID: 12634581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A cross-sectional study of sub-clinical Plasmodium falciparum infection in HIV-1 infected and uninfected populations in Mozambique, South-Eastern Africa.
    Noormahomed EV; Orlov M; do Rosario V; Petersen BW; Guthrie C; Badaro R; Schooley RT
    Malar J; 2012 Aug; 11():252. PubMed ID: 22853699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-minimization comparison of darunavir plus ritonavir and lopinavir/ritonavir in HIV-1 infected treatment-naïve women of childbearing age.
    Möller J; Desai K; Simpson K; Baran RW; Van de Steen O; Dietz B; Gooch K
    J Med Econ; 2014 Apr; 17(4):250-8. PubMed ID: 24351091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Economics of switching to second-line antiretroviral therapy with lopinavir/ritonavir in Africa: estimates based on DART trial results and costs for Uganda and Kenya.
    Simpson KN; Baran RW; Kirbach SE; Dietz B
    Value Health; 2011 Dec; 14(8):1048-54. PubMed ID: 22152173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV-1 Infection Is Associated With Increased Prevalence and Abundance of
    Stiffler DM; Oyieko J; Kifude CM; Rockabrand DM; Luckhart S; Stewart VA
    Front Cell Infect Microbiol; 2020; 10():600106. PubMed ID: 33614525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of malaria parasitaemia in adult HIV-infected patients in Jos, North-central Nigeria.
    Iroezindu MO; Agaba EI; Okeke EN; Daniyam CA; Obaseki DO; Isa SE; Idoko JA
    Niger J Med; 2012; 21(2):209-13. PubMed ID: 23311193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV-malaria co-infection: effects of malaria on the prevalence of HIV in East sub-Saharan Africa.
    Cuadros DF; Branscum AJ; Crowley PH
    Int J Epidemiol; 2011 Aug; 40(4):931-9. PubMed ID: 21224274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growth Recovery Among HIV-infected Children Randomized to Lopinavir/Ritonavir or NNRTI-based Antiretroviral Therapy.
    Achan J; Kakuru A; Ikilezi G; Mwangwa F; Plenty A; Charlebois E; Young S; Havlir D; Kamya M; Ruel T
    Pediatr Infect Dis J; 2016 Dec; 35(12):1329-1332. PubMed ID: 27580060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology of Plasmodium falciparum gametocytemia in India: prevalence, age structure, risk factors and the role of a predictive score for detection.
    Shah NK; Poole C; MacDonald PD; Srivastava B; Schapira A; Juliano JJ; Anvikar A; Meshnick SR; Valecha N; Mishra N
    Trop Med Int Health; 2013 Jul; 18(7):800-9. PubMed ID: 23627694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIV-malaria interactions in North-East India: A prospective cohort study.
    Mohapatra PK; Pachuau E; Kumar C; Borkakoty B; Zomawia E; Singh A; Walia K; Arora R; Mahanta J; Subbarao SK
    Indian J Med Res; 2017 Mar; 145(3):387-394. PubMed ID: 28749403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Study of Malaria Parasite Density in HIV-1 Positive Under-fives in Benin City, Nigeria.
    Okonkwo I; Ibadin M; Sadoh W; Omoigberale A
    J Trop Pediatr; 2018 Aug; 64(4):289-296. PubMed ID: 28977585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlating quantitative real-time PCR to rapid diagnostic test and RNA transcript expression in isolated gametocytemia and asexual parasitemia of
    Lau R; Phuong M; Ralevski F; Boggild AK
    Trop Dis Travel Med Vaccines; 2015; 1():8. PubMed ID: 28883940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Co-trimoxazole Prophylaxis, Asymptomatic Malaria Parasitemia, and Infectious Morbidity in Human Immunodeficiency Virus-Exposed, Uninfected Infants in Malawi: The BAN Study.
    Davis NL; Wiener J; Juliano JJ; Adair L; Chasela CS; Kayira D; Hudgens MG; van der Horst C; Jamieson DJ; Kourtis AP; ;
    Clin Infect Dis; 2017 Aug; 65(4):575-580. PubMed ID: 28444232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa.
    Woodford J; Sagara I; Diawara H; Assadou MH; Katile A; Attaher O; Issiaka D; Santara G; Soumbounou IH; Traore S; Traore M; Dicko OM; Niambele SM; Mahamar A; Kamate B; Haidara B; Sissoko K; Sankare S; Diarra SDK; Zeguime A; Doritchamou JYA; Zaidi I; Dicko A; Duffy PE
    Front Immunol; 2022; 13():959697. PubMed ID: 35990648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical indicators for bacterial co-infection in Ghanaian children with P. falciparum infection.
    Nielsen MV; Amemasor S; Agyekum A; Loag W; Marks F; Sarpong N; Dekker D; Adu-Sarkodie Y; May J
    PLoS One; 2015; 10(4):e0122139. PubMed ID: 25856341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Asymptomatic Malaria Co-infection of HIV-Infected Adults in Nigeria: Prevalence of and Impact on Cognition, Mood, and Biomarkers of Systemic Inflammation.
    Bharti AR; McCutchan JA; Umlauf A; Okwuegbuna OK; Letendre S; Cherner M; Burdo T; Jumare J; Williams K; Blattner W; Royal W
    J Acquir Immune Defic Syndr; 2021 Jan; 86(1):91-97. PubMed ID: 33021552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.